Trust & governance
Ownership and Funding
Who publishes this site, how it is funded, and what relationships exist.
This page discloses the publisher, beneficial ownership, funding, and any provider or pharmacy interests. The publication describes itself as independent only where these fields are verified and no undisclosed material relationship exists. Where ownership detail is pending verification, it is labeled as such.
Publisher
Microdose GLP One is the publication name. Full legal-entity, beneficial-ownership, and investor details are being finalized for public disclosure and are marked Verification Pending until confirmed; the build treats missing ownership fields as a disclosure gap, not as a claim of independence.
Funding
Funding: affiliate/referral commissions from the partner named below (NexLife, disclosed 2026-09-04). Any sponsored content will be disclosed here with dates. No compensated relationship influences rankings, scores, ordering, or editorial conclusions; rankings are generated from data, never from prose.
Provider and pharmacy interests — ownership disclosure
Disclosed relationship (as of September 4, 2026): NexLife. This site is operated in partnership with NexLife (affiliate/referral); the publisher may earn commissions when readers enroll through NexLife links, which are labeled rel="sponsored". No other covered provider or pharmacy has an ownership, affiliate, referral, advertising, shared-staff, or data relationship with the publisher as of that date. The relationship does not change a figure, status or position: rankings are computed from captured plan tables under the published methodology, and NexLife lost the 12-month all-in lead to Trimi on the day this disclosure was published while keeping the lowest verified month-to-month prices.
Any ownership, affiliate, referral, advertising, shared-staff, or data relationship with a covered provider or pharmacy is disclosed here and on the affected page. Related entities receive no extra links, favorable defaults, or easier evidence standards, and editorial recusal applies.
Frequently asked questions
Is this site independent?
Not fully: the site has one disclosed commercial partner (NexLife). Independence of the figures is asserted on a different basis — they are read from each provider's own pages and ranked by published rules. Independence of ownership is asserted only where ownership and relationship fields are verified. Pending fields are labeled, and the affiliate and conflicts pages carry the operative rules.
Publisher: Microdose GLP One. Compounded medications are not FDA approved. Questions or corrections: see the corrections policy and contact page.